DMD06 - The Future of Innovation in the EU – A Europe of Possibilities

Thu, Mar 20, 2025 · 1:00–2:30 PM CET San Francisco Room, Congress Center Basel

About this session

Discover what fuels Europe’s innovation engine. This session discusses the diverse stakeholders that make up the European innovation ecosystem, including R&D, manufacturers, regulators, payers, and patient representatives. We’ll discuss how efficient R&D and robust supply chains contribute to Europe’s global leadership in technological platforms and innovation. We’ll also navigate the complex landscape of Europe’s policy pillars and the reforms proposed by the European Commission. Join us as we examine opportunities to strengthen European innovation and address key concerns such as access, affordability, and availability of medicines.

Programme:
- Panel Discussion with Q&A — Melanie Carr, María Lamas, Gözde S. Briggs, Sabine Atzor, Matias Olsen
- 1. Setting the Scene — Max Dr. Wegner, Yves Jacob

Speakers

Matias Olsen

Associate Director, Public Affairs & Policy · EUCOPE

Panelist
Max Dr. Wegner

Head of Regulatory Affairs · Bayer AG

Chair
Yves Jacob

Head of GRA Key Markets and R&D Lead France · Sanofi-Aventis Recherche & Développement

Chair
Gözde S. Briggs

Senior Programme Manager · European Patients' Forum

Panelist
María Lamas

Executive Director · Spanish Agency for Medicines and Medical Devices (AEMPS)

Panelist
Melanie Carr

Head of Stakeholders and Communication Division · European Medicines Agency

Panelist
Sabine Atzor

Head EU Regulatory Policy · F. Hoffmann La Roche Ltd

Panelist